Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis

Kim, Jungsu, Eltorai, Adam E.M., Jiang, Hong, Liao, Fan, Verghese, Philip B., Kim, Jaekwang, Stewart, Floy R., Basak, Jacob M. +1 more·2012·Journal of Experimental Medicine

DOI 10.1084/jem.20121274

Cited by (161)

Items 101–161 of 161

Mechanistic insights into impaired β-oxidation and its role in mitochondrial dysfunction: A comprehensive review
Amna Aqeel, Areeba Akram, Minahil Ali, Maryam Iqbal, Muhammad Aslam, Rukhma, Fatima Iftikhar Shah · 2025 · Diabetes Research and Clinical Practice
Effects of growth hormone–releasing hormone on sleep and brain interstitial fluid amyloid-β in an APP transgenic mouse model
Fan Liao, Tony J. Zhang, Thomas E. Mahan, Hong Jiang, David M. Holtzman · 2014 · Brain Behavior and Immunity
A flow cytometry–based in vitro assay reveals that formation of apolipoprotein E (ApoE)–amyloid beta complexes depends on ApoE isoform and cell type
Kara, Eleanna, Marks, Jordan D., Roe, Allyson D., Commins, Caitlin, Fan, Zhanyun, Calvo-Rodriguez, Maria, Wegmann, Susanne, Hudry, Eloise, Hyman, Bradley T. · 2018 · Journal of Biological Chemistry
A Systematic Review of Current Progresses in the Nucleic Acid-Based Therapies for Neurodegeneration with Implications for Alzheimer’s Disease
Maryam Selk Ghaffari, Nima Sanadgol, Mohammad Reza Abdollahi · 2020 · Mini-Reviews in Medicinal Chemistry
New insights into innate immunity in Alzheimer’s disease: From APOE protective variants to therapies
Chen, Yun, Holtzman, David M. · 2024 · Trends in Immunology
Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer’s disease or should they be looking elsewhere?
Bruno Pietro Imbimbo, Stefania Ippati, Mark Watling · 2020 · Expert Opinion on Drug Discovery
Deciphering the role of APOE in cerebral amyloid angiopathy: from genetic insights to therapeutic horizons
Hantian Hu, Siqi Wan, Yuetao Hu, Qi Wang, Hanyu Li, Nan Zhang · 2025 · Annals of Medicine
Drain of the brain: low-affinity p75 neurotrophin receptor affords a molecular sink for clearance of cortical amyloid β by the cholinergic modulator system
Saak Victor Ovsepian, Jochen Wolfgang Herms · 2013 · Neurobiology of Aging
Deletion of miR-33, a regulator of the ABCA1–APOE pathway, ameliorates neuropathological phenotypes in APP/PS1 mice
Tate, Mason, Wijeratne, H. R. Sagara, Kim, Byungwook, Philtjens, Stéphanie, You, Yanwen, Lee, Do‐Hun, Gutierrez, Daniela A., Sharify, Daniel, Wells, Megan, Perez‐Cardelo, Magdalena et al. · 2024 · Alzheimer's & Dementia
ApoE: The Non-Protagonist Actor in Neurological Diseases
Lorenzo Grimaldi, Eleonora Bovi, Rita Formisano, Giulia Maria Sancesario · 2024 · Genes
APOE-Targeted Therapeutics for Alzheimer's Disease
Hussein N. Yassine, Cristelle Hugo, Bernadette O’Donovan, Isaiah O. Stephens, Lance A. Johnson, Gregory M. Cole, Julia TCW, Jan O. Johansson, Kassandra Kisler, Ornit Chiba‐Falek · 2025 · Journal of Neuroscience
Role of Adaptive Immune and Impacts of Risk Factors on Adaptive Immune in Alzheimer’s Disease: Are Immunotherapies Effective or Off-Target?
Mingchao Shi, Fengna Chu, Xiaoping Tian, Qiaolifan Aerqin, Feiqi Zhu, Jie Zhu · 2021 · The Neuroscientist
APOE Lipoprotein Particles: Pathophysiology, Therapy, and the Crosstalk in Alzheimer’s Disease and Cardiovascular Disease
Чан Лю, Juan Liu, Yanyang Wang, Shang-Fu Xu, Li-Mei Yu · 2025 · Molecular Neurobiology
The genetic link between systemic autoimmune disorders and temporal lobe epilepsy: A bioinformatics study
Mahdi Malekpour, Seyed Reza Salarikia, Mohammad Kashkooli, Ali A. Asadi‐Pooya · 2023 · Epilepsia Open
Intracerebral Expression of AAV-APOE4 Is Not Sufficient to Alter Tau Burden in Two Distinct Models of Tauopathy
Emily J. Koller, Elsa Gonzalez De La Cruz, Mary J. Weinrich, Tosha Williams, Pedro E. Cruz, Daniel H. Ryu, Todd Eliot Golde, Patrick M. Sullivan, Jada M. Lewis, David Borchelt et al. · 2020 · Molecular Neurobiology
Alzheimer’s disease and immunotherapy: what is wrong with clinical trials?
Yoh Matsumoto, Kuniko Kohyama · 2015 · ImmunoTargets and Therapy
NMDA Inhibitors: A Potential Contrivance to Assist in Management of Alzheimer’s Disease
Sakshi Painuli, Prabhakar Semwal, Wissam Zam, Yasaman Taheri, Shahira M. Ezzat, Peijun Zuo, Liping Li, Dileep Kumar, Javad Sharifi‐Rad, Natália Alves Martins · 2022 · Combinatorial Chemistry & High Throughput Screening
Alzheimer's disease phenotype based upon the carrier status of the apolipoprotein E ɛ4 allele
Xiaoyu Ji, Xinyuan Peng, Hailiang Tang, Hui Pan, W.D. Wang, Jie Wu, Jian Chen, Naili Wei · 2023 · Brain Pathology
Role of astroglia and microglia in Alzheimer's disease and multiple therapeutic interventions
Lei Li, Ying Wang, Qilin Feng, Chaoyang Ma, Cheng He, Wenjun Wan, Lei Tang · 2025 · Journal of Alzheimer s Disease
Advances of therapeutic strategies for Alzheimer’s disease
Xing Guo, Rui-zhu Yue, Zhen Cui, Shuying Wang, Tian Jia, Wenqiang Li, Wei Zhang, Linlin Shan, Chaokun Li · 2025 · Journal of Neurology
New APOE-related therapeutic options for Alzheimer’s disease
Ziying Li · 2019 · AIP conference proceedings
Biological processes and key druggable targets involved in age-associated memory loss: A systematic review
P. Ambili Unni, Girinath G. Pillai, S. Sajithalulu · 2021 · Life Sciences
Alzheimer’s Disease Pharmacology
Germán Plascencia‐Villa, George L. Perry · 2021 · Elsevier eBooks
Relation between Apolipoprotein E in Alzheimer’s Disease and SARS-CoV-2 and their Treatment Strategy: A Review
Anu Kunnath Ramachandran, Subham Das, Gurupur Gautham Shenoy, Jayesh Mudgal, Alex Joseph · 2022 · CNS & Neurological Disorders - Drug Targets
Amyloid β Hypothesis in the Development of Therapeutic Agents for Alzheimer’s Disease
Adegoke O. Adeniji, P.W. Adams, Vicky V. Mody · 2016 · Elsevier eBooks
Prevalence of ApoE Alleles in a Spanish Population of Patients with a Clinical Diagnosis of Alzheimer’s Disease: An Observational Case-Control Study
Laura Bello-Corral, Jesús Seco‐Calvo, Ángela Molina Fresno, Ana Isabel González, Ana M. Llorente, Diego Fernández‐Lázaro, Leticia Sánchez-Valdeón · 2024 · Medicina
SPROUT: spectral sparsification helps restore the spatial structure at single-cell resolution
Jingwan Wang, Shiying Li, Lingxi Chen, Shuai Cheng Li · 2022 · NAR Genomics and Bioinformatics
Novel therapeutic approaches for targeting Alzheimer’s disease
Akruti Khodakiya, Sunita Chaudhary, Ankit Chaudhary, Bhupendra Gopalbhai Prajapati · 2024 · Elsevier eBooks
Hat die Alzheimer-Forschung versagt?
Christian Haass, Johannes Levin · 2019 · Der Nervenarzt
Diabetes and Alzheimer’s Disease
Shuko Takeda, Ryuichi Morishita · 2017 · Springer eBooks
APOE4 and prevalence of degenerative cervical myelopathy: A genetic case-control study in the UK Biobank cohort
Renuka Chintapalli, Oliver Daniel Mowforth, Benjamin Marshall Davies · 2025 · Journal of Clinical Neuroscience
Perspectives on the Role of APOE4 as a Therapeutic Target for Alzheimer’s Disease
Kavita Patel, Siwangi Srivastava, Shikha Kushwah, Ashutosh Mani · 2021 · Journal of Alzheimer s Disease Reports
Deletion of neuronal <i>Idol</i> ameliorates Alzheimer's disease–related pathologies via APOE receptors
Karahan, Hande, Hartigan, Kelly, Al‐Amin, Md Mamun, John, Sutha K., McCord, Brianne, Wijeratne, H. R. Sagara, Acri, Dominic J., Smith, Daniel C., Dabin, Luke C., Cordero, Hannah M. Rondon et al. · 2025 · Alzheimer's & Dementia
Spontaneous mammalian models for Alzheimer's disease and dementia
Madeleine Ford, Frank J. Gunn‐Moore, Mark Patrick Dagleish · 2025 · Brain Communications
Comparison of the ApoE allelic variants in the formation of intracerebral Aβ deposits
Guilian M. Xu, Conner Angelle, Divya Huilgol, Patricia Sacilotto, Karen N. McFarland, Susan Fromholt, Amanda Lopez, Quan Vo, Andrea Rivasplata, Selma Brkic et al. · 2025 · Neurobiology of Disease
Linking Cerebral Malaria Pathogenesis to APOE-Mediated Amyloidosis: Observations and Hypothesis
Kioko Mwikali, Shaban Mwangi, James M. Njunge, James Alexander Berkley, Philip Bejon, Abdirahman I. Abdi · 2024 · Molecular Neurobiology
Linking cerebral malaria pathogenesis to APOE-mediated amyloidosis
Kioko Mwikali, Shaban Mwangi, James M. Njunge, James Alexander Berkley, Philip Bejon, Abdirahman I. Abdi · 2023 · Research Square
Neuronal APOE4 alone is sufficient to drive tau pathology, neurodegeneration, and neuroinflammation in an Alzheimer’s disease mouse model
Jessica R. Blumenfeld, Yaqiao Li, Min Joo Kim, Oscar Yip, Leon Yao, Samuel De Leon, Rebecca Fulthorpe, David M. Shostak, Zoe Platow, Kaylie Suan et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Frontiers and hotspots evolution between air pollution and Alzheimer's disease: A bibliometric analysis from 2013 to 2023
Zhirong Liu, Bingshuang Hu, Ju Tang, Xinlian Liu, BaoJing Cheng, Cui Jia, Lushun Zhang · 2024 · Journal of Alzheimer s Disease
Multiscale Approximations to Understand the Complex Role of Microglia in Alzheimer's Disease
Patricia Martínez-Tazo, Marina Mejias‐Ortega, Verónica López-López, Aysha María Bhojwani-Cabrera, Emma Saxton, Santiago Canals, Giles E. Hardingham, Antonia Gutiérrez, José P. López‐Atalaya, Silvia De Santis · 2026 · European Journal of Neuroscience
The aqueous phase of Alzheimer's disease brain contains assemblies built from w4 and w7 kDa Ab species
Jessica M. Mc Donald, Wen Liu, Alexandra J. Mably, Gunnar Brinkmalm, Erik Portelius, William M. Wittbold, Matthew P. Frosch, Dominic M. Walsh · 2015
Hat die Alzheimer-Forschung versagt?: Das Scheitern amyloidbasierter klinischer Studien
Christian Haass, Johannes Levin · 2019 · Der Nervenarzt
Domino-like Effect of C112R Mutation on ApoE4 Aggregation and Its Reduction by Alzheimer’s Disease Drug Candidate
Michal Nemergut, Sérgio M. Marques, Lukáš Uhrík, Tereza Váňová, Markéta Nezvedová, Darshak Chandulal Gadara, Durga Jha, Jan Tulis, Veronika Novakova, Joan Planas-Iglesias et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Alzheimer’s Disease Therapeutics Targeting Apolipoprotein E
Fan Liao, David M. Holtzman · 2016 · Elsevier eBooks
Targeting Astrocytes With Viral Gene Therapy for Alzheimer’s Disease
Zachary P. Rosenthal, Andrew W. Kraft, Leah R. Czerniewski, Jin‐Moo Lee · 2018 · Elsevier eBooks
Spectral sparsification helps restore the spatial structure at single-cell resolution
Jingwan Wang, Shiying Li, Lingxi Chen, Shuai Cheng Li · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Additional file 2 of Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance
Weixi Feng, Yanli Zhang, Ze Wang, Hanrong Xu, Ting Wu, Charles Marshall, Junying Gao, Ming Xiao · 2020 · Figshare
Human APOE allelic variants suppress the formation of diffuse and fibrillar Aβ deposits relative to mouse Apoe in transgenic mouse models of Alzheimer amyloidosis
Guilian M. Xu, Patricia Sacilotto, Carmelina Gorski, Parul Bali, Susan Fromholt, Quan Vo, Karen N. McFarland, Qing Lu, David Borchelt, Paramita Chakrabarty · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Relationship Between Dyslipidemia and Alzheimer’s Disease
Murat Bolayırlı, Mine Kücür · 2024
ApoE and Cerebrovascular Disease
Ludmila Belayev, Carlos M. Vieira, Reinaldo B. Oriá, Nicolas Guillermo Bazan · 2025 · Springer eBooks
Amyloid β hypothesis in the development of therapeutic agents for Alzheimer's disease
Adegoke O. Adeniji, Caitlyn Johnson, Vicky V. Mody · 2025 · Elsevier eBooks
Additional file 3 of Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer’s Disease drug candidate
Michal Nemergut, Sérgio M. Marques, Lukáš Uhrík, Tereza Váňová, Markéta Nezvedová, Darshak Chandulal Gadara, Durga Jha, Jan Tulis, Veronika Novakova, Joan Planas-Iglesias et al. · 2023 · Figshare
Additional file 1 of Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance
Feng, Weixi, Zhang, Yanli, Ze Wang, Xu, Hanrong, Wu, Ting, Charles Marshall, Gao, Junying, Xiao, Ming · 2020 · Figshare
Additional file 1 of Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer’s Disease drug candidate
Michal Nemergut, Sérgio M. Marques, Lukáš Uhrík, Tereza Váňová, Markéta Nezvedová, Darshak Chandulal Gadara, Durga Jha, Jan Tulis, Veronika Novakova, Joan Planas-Iglesias et al. · 2023 · Figshare
Additional file 2 of Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer’s Disease drug candidate
Michal Nemergut, Sérgio M. Marques, Lukáš Uhrík, Tereza Váňová, Markéta Nezvedová, Darshak Chandulal Gadara, Durga Jha, Jan Tulis, Veronika Novakova, Joan Planas-Iglesias et al. · 2023 · Figshare
Neutralizing hepatic apolipoprotein E enhances aged bone fracture healing
Mingjian Huang, Abhinav Reddy Balu, Kristin Happ Molitoris, Akshay Bareja, Gurpreet Singh Baht · 2026 · Bone Research
The Role of ApoE Genetics in Glial Lipid Metabolism and Inflammation
Julia TCW, Renu Negi, Margareta Kurkela · 2025 · Springer eBooks
Caractérisation du site de liaison du cholestérol sur l'APP : un modulateur de la sécrétion de peptides amyloïdes
Linda Hanbouch · 2017 · theses.fr (ABES)
The Role of ApoE Genetics in Glial Lipid Metabolism and Inflammation
Julia TCW, Renu Negi, Margareta Kurkela · 2026 · Springer eBooks
Overinvestment in ultra‑rare APOE variants and highly speculative apoE–inhibitor docking risks undermining translational progress in sporadic Alzheimer’s disease
Jean-Numa Gillet · 2026 · Journal of Biomolecular Structure and Dynamics
Emerging therapeutic strategies to target APOE4 in Alzheimer's disease
Wei I. Jiang, 王冰莹, Dengke K. Ma · 2026 · FEBS Journal